Medicine
 |
|
17 may 2022 23:20:04 |
| SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer (BMC Medical Genomics) |
|
Tweet The roles and clinical values of synaptojanin 2 (SYNJ2) in lung squamous cell carcinoma (LUSC) remain unclear. |
| 137 viewsCategory: Genomics, Medicine |
 Identification of a novel CNV at the EYA4 gene in a Chinese family with autosomal dominant nonsyndromic hearing loss (BMC Medical Genomics)Clinical and molecular findings in a Chinese family with a de novo mitochondrial A1555G mutation (BMC Medical Genomics) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
